Novartis Ag (NVS) Invested Capital (2017 - 2025)
Novartis Ag (NVS) has disclosed Invested Capital for 9 consecutive years, with $46.4 billion as the latest value for Q4 2025.
- Quarterly Invested Capital rose 3.99% to $46.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.4 billion through Dec 2025, up 3.99% year-over-year, with the annual reading at $46.4 billion for FY2025, 3.99% up from the prior year.
- Invested Capital hit $46.4 billion in Q4 2025 for Novartis Ag, up from $44.6 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $90.7 billion in Q4 2022 to a low of $44.6 billion in Q4 2024.
- Historically, Invested Capital has averaged $59.8 billion across 5 years, with a median of $47.4 billion in 2023.
- Biggest five-year swings in Invested Capital: skyrocketed 10355.86% in 2021 and later plummeted 47.76% in 2023.
- Year by year, Invested Capital stood at $69.6 billion in 2021, then skyrocketed by 30.23% to $90.7 billion in 2022, then tumbled by 47.76% to $47.4 billion in 2023, then fell by 5.75% to $44.6 billion in 2024, then grew by 3.99% to $46.4 billion in 2025.
- Business Quant data shows Invested Capital for NVS at $46.4 billion in Q4 2025, $44.6 billion in Q4 2024, and $47.4 billion in Q4 2023.